Martijn P. Lolkema
529 works · 14,762 citations · h-index 55
Top works
- Natural adjuvants: Endogenous activators of dendritic cells
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- Stromal biology and therapy in pancreatic cancer
- Pan-cancer whole-genome analyses of metastatic solid tumours
- Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)
- Genetic analysis of von Hippel-Lindau disease
- Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells
- CopywriteR: DNA copy number detection from off-target sequence data
- The mutational footprints of cancer therapies
- A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF -Mutant Colorectal Cancer
- The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
- Ethical, Legal, and Counseling Challenges Surrounding the Return of Genetic Results in Oncology
- A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
- Platelets Take Up the Monoclonal Antibody Bevacizumab
- Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study
- Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review
- Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study
- Application of circulating tumor DNA in prospective clinical oncology trials – standardization of preanalytical conditions